Plasma immune proteome-based risk score predicts survival in advanced gastric cancer treated with PD-1 inhibitors and chemotherapy

BackgroundBlood-based biomarkers that capture systemic immunity could complement tissue-based assays for prognostication in advanced gastric cancer receiving programmed cell death protein 1 (PD-1)–based chemoimmunotherapy. We evaluated whether baseline plasma immune proteomics can stratify clinical...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Zhouwei Zhan, Ruyu Lin, Yigui Chen, Sha Huang, Luping Lin, Hanchen Zheng, Xiaojie Wang, Xiaoyan Lin, Zengqing Guo, Qiaoting Hu, Bijuan Chen
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Frontiers Media S.A. 2026-01-01
Serie:	Frontiers in Immunology
Soggetti:	gastric cancer immunotherapy plasma proteomics risk score nomogram prognosis
Accesso online:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1715993/full
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!